Eledon Pharmaceuticals, Inc.

ELDN·NASDAQ·$3.89Share Price as of 11/2·$233MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/19/26 10-QQ3 ended 09/30/2511/14/25 10-K/AFY 202408/14/25

Disclosures

8-KCurrent report08/13/26 8-KCurrent report06/22/26 8-KCurrent report05/13/26 8-KCurrent report03/19/26 8-KCurrent report01/02/26

Prospectuses and Registrations

S-8Registration of securities for employees09/04/26 S-3Shelf registration05/01/26 424B5Prospectus supplement11/13/25 424B5Prospectus supplement11/12/25 424B5Prospectus supplement10/30/24

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 PRE 14APreliminary proxy04/21/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25

Ownership

Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26 SC 13GBeneficial ownership07/31/26 SC 13G/ABeneficial ownership (amended)05/15/26 SC 13G/ABeneficial ownership (amended)03/26/26

Other

EFFECTRequest for effectiveness05/11/26 CORRESPCorrespondence with the SEC05/07/26 UPLOADLetter from the SEC05/07/26 ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders04/29/25